Search

everythinglearnresearchcommunity

for

Search:↓

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Electron Beam Tomography (EBT) is a useful additional test to stress testing for detecting heart disease.

Certain factors like patchy hair loss at the back of the head, being female, and younger age at diagnosis can lead to a worse outcome for alopecia areata.

Female pattern hair loss is linked to genetics, family history, and lifestyle factors.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Early hair whitening may indicate a higher risk of heart disease in young and middle-aged men.

Spanlastic nanovesicles can improve efinaconazole delivery through nails.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

A new model helps predict treatment success in girls with early puberty.

Pigmented vellus and upright regrowing hairs predict hair regrowth in severe alopecia.

Darkened knuckles can be an early sign of insulin resistance.

Machine learning improves DNA predictions for eye and hair color, but challenges remain for skin tone and facial features.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Increased LC3 gene expression may be linked to premature graying of hair.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Severe alopecia areata may increase the risk of heart-related diseases.

Men with androgenetic alopecia may have a higher risk of heart rhythm problems.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Forensic DNA Phenotyping can now better predict appearance, ancestry, and age from DNA, but more research is needed for precise police use.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

ATR-FTIR spectroscopy could help monitor alopecia areata treatment response non-invasively.